CORC

浏览/检索结果: 共18条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
Chinese expert consensus on diagnosis and treatment of nasopharyngeal carcinoma: evidence from current practice and future perspectives 期刊论文
CANCER MANAGEMENT AND RESEARCH, 2019, 卷号: 11
作者:  Lang, Jinyi;  Hu, Chaosu;  Lu, Taixiang;  Pan, Jianji;  Lin, Tongyu
收藏  |  浏览/下载:19/0  |  提交时间:2019/12/05
Correction to: EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways. 期刊论文
Journal of Experimental & Clinical Cancer Research, 2019, 卷号: Vol.38 No.1
作者:  Lin, Cheng;  Zong, Jingfeng;  Lin, Wansong;  Wang, Minghui;  Xu, Yuanji
收藏  |  浏览/下载:22/0  |  提交时间:2019/12/13
Correction to: EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways. 期刊论文
Journal of experimental & clinical cancer research, 2019, 卷号: Vol.38 No.1, 页码: 34
作者:  Cheng Lin;  Jingfeng Zong;  Wansong Lin;  Minghui Wang;  Yuanji Xu
收藏  |  浏览/下载:33/0  |  提交时间:2019/12/13
Correction to: EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways 期刊论文
Journal of Experimental & Clinical Cancer Research, 2019, 卷号: Vol.38 No.1
作者:  Cheng Lin;  Jingfeng Zong;  Wansong Lin;  Minghui Wang;  Yuanji Xu
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/13
EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways 期刊论文
Journal of Experimental & Clinical Cancer Research, 2018, 卷号: Vol.37 No.1, 页码: 1-14
作者:  Cheng Lin;  Jingfeng Zong;  Wansong Lin;  Minghui Wang;  Yuanji Xu
收藏  |  浏览/下载:11/0  |  提交时间:2019/12/26
Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial 期刊论文
The Lancet, 2016, 卷号: 388, 期号: 10054, 页码: 1883-1892
作者:  Zhang, Li*;  Huang, Yan;  Hong, Shaodong;  Yang, Yunpeng;  Yu, Gengsheng
收藏  |  浏览/下载:11/0  |  提交时间:2019/12/03
Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial 期刊论文
LANCET, 2016, 卷号: 388, 期号: 10054
作者:  Huang, Yan;  Cao, Xiaolong;  Wang, Rensheng;  Lu, Xiaojun;  Chen, Dongping
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/05
Platinum‐based chemotherapy plus cetuximab first‐line for Asian patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: Results of an open‐label, single‐arm, multicenter trial 期刊论文
Head & Neck, 2015, 卷号: 37, 期号: 8, 页码: 1081-1087
作者:  Guo, Ye;  Shi, Mei;  Yang, Ankui;  Feng, Jifeng;  Zhu, Xiaodong
收藏  |  浏览/下载:9/0  |  提交时间:2019/12/03
Platinum-based chemotherapy plus cetuximab first-line for Asian patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: Results of an open-label, single-arm, multicenter trial 期刊论文
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2015, 卷号: 37, 期号: 8
作者:  Guo, Ye;  Shi, Mei;  Yang, Ankui;  Feng, Jifeng;  Zhu, Xiaodong
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/19
Platinum-based chemotherapy plus cetuximab first-line for Asian patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: Results of an open-label, single-arm, multicenter trial 期刊论文
2015, 卷号: 37, 期号: 8, 页码: 1081-1087
作者:  Guo, Ye;  Shi, Mei;  Yang, Ankui;  Feng, Jifeng;  Zhu, Xiaodong
收藏  |  浏览/下载:5/0  |  提交时间:2020/01/13


©版权所有 ©2017 CSpace - Powered by CSpace